HALISTER: MannKind’s Afrezza Faces FDA Scrutiny on Third Effort

MannKind’s Afrezza Faces FDA Scrutiny on Third Effort

Alert: HALISTER Source: BFW (Bloomberg First Word)

Tickers MNKD US (MannKind Corp) LLY US (Eli Lilly & Co) NOVOB DC (Novo Nordisk A/S) PFE US (Pfizer Inc)

People Matthew Pfeffer (MannKind Corp)

Topics Diabetes

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283